Tags:FinTechInformationTechnologyWeb
iPierian is a South San Francisco-based biopharmaceutical company focused on the industrialization of induced pluripotent stem cell (iPS) technology with the mission of creating new therapeutics through cellular reprogramming and directed differentiation of patient cells. The initial focus of the company is in neurodegeneration, particularly spinal muscular atrophy (SMA), amyotrophic lateral sclerosis (ALS) and Parkinson’s disease as well as in cardiovascular disease, where iPierian has a collaboration with The Gladstone Institute of Cardiovascular Disease and Dr. Deepak Srivastava, the institute’s director. iPierian plans to enhance its partnership efforts to further expand into metabolic diseases. iPierian, Inc. is backed by a group of top-tier investors including Kleiner Perkins Caufield & Byers, Highland Capital Partners, MPM Capital and FinTech Global Capital. For more information on iPierian, Inc., please visit their web site at www.ipierian.com.
Total raised: $52M

Investors 1

DateNameWebsite
-ATEL Capit...atel.com

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
04.09.2013-$30M-medcitynew...
08.07.2010Series B$22M-finsmes.co...

Mentions in press and media 11

DateTitleDescriptionCategoryAuthorSource
18.10.2013Health IT ...Here were the biggest health I...--medcitynew...
04.09.2013iPierian R...iPierian, Inc., a South San Fr...funding U...-finsmes.co...
04.09.2013UPDATED: P...iPierian CEO Nancy Stagliano ...Venture Ca...-fiercebiot...
04.09.2013Neuro drug...MPM Capital co-led the round a...--medcitynew...
26.04.2013Google Ven...DNAnexus The bioinformatics co...--medcitynew...
07.10.2010Athersys C...Athersys Inc. (NSDQ:ATHX) CEO ...-MedCity Ne...massdevice...
08.09.2010iPierian h...iPierian, Inc., a South San Fr...funding U...-finsmes.co...
08.07.2010iPierian C...iPierian, Inc., a South San Fr...funding U...-finsmes.co...
-Google Ven...Google Ventures has been backi...--medcitynew...
-Health IT ...Investments in electronic heal...--medcitynew...
Show more